We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$11.9B
AUM Growth
+$496M
Cap. Flow
-$115M
Cap. Flow %
-0.97%
Top 10 Hldgs %
15.43%
Holding
2,070
New
161
Increased
956
Reduced
764
Closed
161

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$33.2M
2
MSFT icon
Microsoft
MSFT
+$31.9M
3
AMZN icon
Amazon
AMZN
+$21.3M
4
NVDA icon
NVIDIA
NVDA
+$20M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$14.6M

Sector Composition

Rank Sector Weight
1 Technology 20.77%
2 Healthcare 10.79%
3 Financials 8.54%
4 Industrials 7.76%
5 Consumer Discretionary 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCK icon
1501
Crown Holdings
CCK
$13.1B
$483K ﹤0.01%
5,843
-557
-9% -$47.1K
WIT icon
1502
Wipro
WIT
$20B
$482K ﹤0.01%
+214,702
New +$511K
MPLX icon
1503
MPLX
MPLX
$59.7B
$482K ﹤0.01%
13,991
+1,290
+10% +$44.3K
ADUS icon
1504
Addus HomeCare
ADUS
$2.23B
$480K ﹤0.01%
4,496
+779
+21% +$81.3K
PYN
1505
DELISTED
PIMCO New York Municipal Income Fund III
PYN
$479K ﹤0.01%
74,090
+22,223
+43% +$145K
CRK icon
1506
Comstock Resources
CRK
$3.94B
$478K ﹤0.01%
44,306
-6,788
-13% -$80.7K
CPE
1507
DELISTED
Callon Petroleum Company
CPE
$476K ﹤0.01%
14,244
-1,061
-7% -$40K
SAVE
1508
DELISTED
Spirit Airlines, Inc.
SAVE
$473K ﹤0.01%
27,552
-4,905
-15% -$91.6K
EGRX
1509
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$473K ﹤0.01%
16,667
+697
+4% +$20.7K
DAN icon
1510
Dana Inc
DAN
$3.06B
$473K ﹤0.01%
31,396
-14,455
-32% -$237K
VRTS icon
1511
Virtus Investment Partners
VRTS
$1.1B
$472K ﹤0.01%
2,479
+151
+6% +$30.5K
ABR icon
1512
Arbor Realty Trust
ABR
$998M
$470K ﹤0.01%
40,900
+5,338
+15% +$74K
SEIC icon
1513
SEI Investments
SEIC
$12.6B
$469K ﹤0.01%
8,147
+1,342
+20% +$80.5K
EPD icon
1514
Enterprise Products Partners
EPD
$81.7B
$467K ﹤0.01%
18,047
+1,667
+10% +$42.8K
CVLT icon
1515
Commault Systems
CVLT
$5.61B
$462K ﹤0.01%
8,139
-175
-2% -$10.4K
NX icon
1516
Quanex
NX
$1.01B
$461K ﹤0.01%
+21,428
New +$514K
NTG
1517
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
$461K ﹤0.01%
13,831
-6,994
-34% -$248K
GHIXW
1518
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$460K ﹤0.01%
1,999,998
GXO icon
1519
GXO Logistics
GXO
$5.55B
$460K ﹤0.01%
9,112
-1,443
-14% -$71.8K
PBH icon
1520
Prestige Consumer Healthcare
PBH
$2.6B
$459K ﹤0.01%
7,332
-9,100
-55% -$568K
KT icon
1521
KT
KT
$8.81B
$458K ﹤0.01%
40,382
+2,775
+7% +$35.5K
SHO icon
1522
Sunstone Hotel Investors
SHO
$2.06B
$458K ﹤0.01%
46,349
+704
+2% +$7.14K
MLKN icon
1523
MillerKnoll
MLKN
$1.67B
$456K ﹤0.01%
22,318
+10,129
+83% +$228K
CHWY icon
1524
Chewy
CHWY
$9.63B
$455K ﹤0.01%
12,161
+4,435
+57% +$184K
HII icon
1525
Huntington Ingalls Industries
HII
$12.8B
$453K ﹤0.01%
2,186
+631
+41% +$136K

Similar funds

Guggenheim Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Guggenheim Capital held 2,070 positions worth $11.9B, up 4.4% from $11.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Guggenheim Capital's Q1 2023 filing shows 161 new, 956 increased, 764 reduced and 161 closed positions. Its largest new stake was Certara: 199,189 shares worth $4.8M. The largest sale was FIGS, an estimated $43.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Guggenheim Capital's largest Q1 2023 buy was Certara: 199,189 shares worth $4.8M.
  • Guggenheim Capital added most to Apple in Q1 2023, an estimated $33.2M increase.
  • Guggenheim Capital's biggest Q1 2023 reduction was FIGS, cutting an estimated $43.6M.
  • Guggenheim Capital fully exited MSD Acquisition Corp. Class A Ordinary Shares in Q1 2023, selling an estimated $21.9M.
  • Guggenheim Capital's ten largest holdings make up 15% of its $11.9B portfolio in Q1 2023.
  • Guggenheim Capital opened 161 new positions and closed 161 in Q1 2023.
  • Guggenheim Capital's portfolio value rose 4.4% quarter-over-quarter to $11.9B.

Based on Guggenheim Capital's 13F filing for Q1 2023, filed 11 May 2023.